æ±å大å¦ãä¸è¬å ¥è©¦ã廿¢ï¼ï¼æ¥æ¬ã®å¤§å¦ãããã¼ãã¼ãã¹ãããªããªãæ¥
æ¥æ¬ã«ãããå¤§è ¸ããã®ç¾ç¶ã¨åé¡ç¹ 以åã®æ¥æ¬ã§ã¯ãã¾ãå¤ããªãã£ãå¤§è ¸ããã¯ãæä»£ã¨ã¨ãã«çæ´»ç¿æ £ãå¤åãã40å¹´ä½ãã§ãç´7åã«ãªã£ã¦ãã¾ãã ã¾ããä»ã®ããã«æ¯ã¹ã¦é²è¡ãé ããããã¹ãã¼ã¸â ï½â ¡ã§ã¯90%ãæ²»ãç æ°ã§ããã«ãããããããå¤§è ¸ããã®æ»äº¡æ°ã¯ç·æ§ã§2ä½ã女æ§ã§1ä½ã¨ãªã£ã¦ãã¾ãã ã¤ã¾ããæ©æã®æ®µéã§çºè¦ã§ãã¦ããªãã¨ãããã¨ã§ãã æ¥æ¬ã®å¤§è ¸ããæ¤è¨ºã¯1次ã¹ã¯ãªã¼ãã³ã°ã§ä¾¿æ½è¡æ¤æ»ãè¡ãã¾ãã 便æ½è¡æ¤æ»å ç«æ³ã®æåº¦ï¼å¤§è ¸ãããããå ´åã«ä¾¿æ½è¡æ¤æ»ã齿§ã¨ãªã確çï¼ã¯ã対象ã¨ããç å¤ã®é²è¡åº¦ãç®åºæ¹æ³ã«ãã£ã¦ããªãã®å·®ãããã30.0%ï½92.9%ã¨ãªãã¾ãã ããã¯ãå¤§è ¸ã®åºè¡ãæ¾ãä¸ããæ¤æ»ãªã®ã§ãã¾ã è «çãå°ããåºè¡ãã¦ããªãå ´åãè «çã大ãããªã£ã¦ãåºè¡ãã¦ããªãå ´åã¯è¦éãã¦ãã¾ãã¾ãã ã¾ããçã§æ¯å齿§ã«ãªã£ã¦ãã¾ãäººãæ¥ããããã¦ç²¾å¯æ¤æ»ãåããªã人ãå¤
ãã®ã³ã¼ãã¼ã§ã¯ã2014å¹´ããå 端ãã¯ããã¸ã¼ã®ç ç©¶ãè«æåä½ã§è¨äºã«ãã¦ããWebã¡ãã£ã¢ãSeamlessãï¼ã·ã¼ã ã¬ã¹ï¼ã主宰ããå±±ä¸è£æ¯ æ°ãå·çãæ°è¦æ§ã®é«ãç§å¦è«æã山䏿°ãããã¯ã¢ãããã解説ããã Xï¼ ï¼ shiropen2 LINEã¤ãã¼ã«æå±ããå±±ä¸ç¥¥å¤ªãããçºè¡¨ããè«æãå®è³ªçã«ç¡é大ãµã¤ãºãæã¤ã¿ã¼ã²ããã®ãã¤ã³ãã£ã³ã°ï¼ 2025 年大å¦å ¥å¦å ±éãã¹ããæ å ± Iãåé¡ã®ä¸èå¯ãã¯ã2025å¹´ã®å¤§å¦å ¥å¦å ±éãã¹ããæ å ±Iãã«ããã¦åºé¡ããããã¦ã¹ã«ã¼ã½ã«ã§ã®ã¿ã¼ã²ãã鏿ã«é¢ããåé¡ã«ã¤ãã¦ããã®å¦¥å½æ§ãèå¯ããç ç©¶å ±åã§ããã åé¡ã¯ãç»é¢ä¸ã«é ç½®ããã4ã¤ã®ã¿ã¼ã²ããï¼0ï½3ï¼ãããæãçæéã§ã¯ãªãã¯ã§ãããã®ãé¸ã¶ã¨ãããã®ã§ããããã®åé¡ã¯ãã£ããã®æ³åã«åºã¥ãã¦ãããã¿ã¼ã²ããã大ããã»ã©ãã¾ãã¿ã¼ã²ããã¨ã«ã¼ã½ã«ãè¿ãã»ã©ããã¤ã³ãã£ã³ã°æéãçããªã
è¡æ¶²æ¤æ»ã§ã¢ã«ããã¤ãã¼ç ã診æã§ããã°ç»æçã ãæ°ãã«éçºãããè¡æ¶²æ¤æ»ã¯ãæäººã®ã¢ã«ããã¤ãã¼ç ã90ï¼ ã®ç²¾åº¦ã§è¨ºæã§ããã¨ãããç¾æç¹ã§ã¯ã診æã«ã¯ããä½ã¸ã®è² æ ã大ããè³è髿¶²ã®æ¤æ»ãPETæ¤æ»ãå¿ è¦ã ãï¼PHOTOGRAPH BY FLORENTIN CATARGIU, 500PX/GETTY IMAGESï¼ ç§å¦è ãã¡ã¯é·å¹´ãè¡æ¶²æ¤æ»ã«ãã£ã¦ã¢ã«ããã¤ãã¼ç ã®è¨¼æ ãè¦ã¤ããæ¹æ³ã®éçºã«åãçµãã§ããããã®ã»ã©ãå¹³åçãªå»å¸«ã®è¨ºæãã精度ãé«ãæ°ææ³ã«ã¤ãã¦ã®è«æãã7æ28æ¥ä»ãã§å»å¦èªãJournal of the Medical American Associationï¼JAMAï¼ãã«æ²è¼ãããç±³å½ãã£ã©ãã«ãã£ã¢ã§éå¬ãããå½éã¢ã«ããã¤ãã¼ç å¦ä¼ï¼AAICï¼ã§ãçºè¡¨ãããããã®æ¹æ³ã¯ä»ã®ã¨ãããçºçåã®æ¤æ»ã¨ãã¦ä½¿ããã¨ã¯æ¨å¥¨ããã¦ããªãããçºçå¾ã®æ¤æ»ãåãããããªã
â»æ°åã³ããã¦ã¤ã«ã¹ææçã®æ¤æ»ã«ä¿ãä¿éºåè¼ä¾¡æ ¼ãæ¹æ£ããã¾ããã 令å4å¹´7æ1æ¥ãã700ç¹ã¨ãªãã¾ãããã®æ¹æ£ã«ä¼´ããå½ç¤¾æ¤æ»ä¾¡æ ¼ãè¦ç´ãã¾ããã æ°åã³ããã¦ã¤ã«ã¹PCRæ¤æ»ï¼å¤ç°åç¹å®æ¤æ» ï¼å»çæ©é¢åãã»ä¿éºé©ç¨ï¼ æ°åã³ããã¦ã¤ã«ã¹ã®ã¹ã¯ãªã¼ãã³ã°ãç®çã¨ãããã«ããã¬ãã¯ã¹æ³ãç¨ããPCRæ¤æ»ã¨é½æ§æ¤ä½ã«ãããå¤ç°åç¹å®æ¤æ»ãéå§ãããã¾ãããå¤ç°åç¹å®æ¤æ»ã§ã¯ãKogenBiotech社ã®ãæ°åã³ããã¦ã¤ã«ã¹Séºä¼åå¤ç°æ¤åºè©¦è¬ããç¨ãã¦ããªãã¯ãã³æ ªï¼BA.1, BA.2, BA.3, BA.4, BA.5ï¼ã»ãã¼ã¿æ ªã»ã¬ã³ãæ ªã»ãã«ã¿æ ªã»ã©ã ãæ ªã»ãã¥ã¼æ ªã»ã¢ã«ãã¡æ ªã®è¤æ°ã®å¤ç°æ ªãæ¤åºãã¾ãã å人åãã®æ°åã³ããã¦ã¤ã«ã¹éµéPCRæ¤æ»ã宿½ãã¦ããã¾ãã ï¼å人åãæ°åã³ããã¦ã¤ã«ã¹éµéæ¤æ»ï¼ æ¬æ¤æ»ã®ç¹å¾´ 齿§/é°æ§ã®å¤å®ãé«ç²¾åº¦ã§è¡ãã¾ã å½ç¤¾ã®PCRæ¤æ»ã§
容éãå½è£ ããå½ç©ã®å¤§å®¹éUSBã¡ã¢ãªãæ¤åºããããªã¼ã½ããã»ã¢ããªãValiDriveããç»å ´ãã¾ããã ãValiDriveããã©ããã£ããã®ããå¶ä½è ã®Gibson Research Corporationã¯ä»¥ä¸ã®ããã«è¿°ã¹ã¦ãã¾ãã ç§ã¯æ ¼å®ã§å£²ããã¦ãã1TBããã³2TBã®USBã¡ã¢ãªã12å°è³¼å ¥ãã¾ããããããããã®ãã¹ã¦ã容éãå½è£ ããå½ç©ã§ããã å½ç©ã®USBã¡ã¢ãªã¯PCä¸ã§ã¯1TBããã³2TBã¨ãã¦èªèããã¾ããããããå®éã«ã¯64GBããããã¾ããã§ããã使ç¨éã64GBãè¶ ããã¨ãæ°ãããã¡ã¤ã«ã¯ä¿åãããªããªãã¾ããPCä¸ã§ã¯ãã¡ã¤ã«ãåå¨ããããã«è¦ãã¾ãããã¹ãã¬ã¼ã¸ä¸ã«ã¯åå¨ããªããããã¡ã¤ã«ãéãã¦ãä¸èº«ã¯ç©ºã£ã½ã§ãã
. æåæ¤æ»ãããã«ãã齿§åå¿ç17.6ï¼ ï¼ç²¾åº¦ï¼ã¨ãªãã¾ãã ï¼â»ææå¾3-7æ¥ä»¥å ã®é½æ§è ã®ãã¼ã¿ã®ãããæ¤æ»ç²¾åº¦ã«ãã©ãããåå¨ãããã¨ãäºããäºæ¿ãã ããï¼ . â»å½ãµã¤ãã¸ã®æ å ±ã®æ²è¼ã¯ãããã¾ã§å®ç¸¾ã«åºã¥ãæ¤è¨¼çµæã§ããçµæãã¼ã¿ã«ã¤ãã¦ã¯ä¸å ¨ãæãã¦ããã¾ãããå½ãµã¤ããä»ãã¦åå¾ãããæ å ±ã«é¢ãã¦ããã®å 容ã®ä¿è¨¼ãåã³è²¬ä»»ã¯ä¸åè² ãã¾ããã [2022/1 ææ°æ å ±]ãâãã»ã¼å ¨ã¦ã®æåæ¤æ»ãããããã¥ã¢ã«ã«ã¯ã15åçµéã§é°æ§é½æ§å¤æãã§ããã¨æè¨ããã¦ãã¾ããããªãã¯ãã³ä»¥éãèè ã®æ¤è¨¼çµæã§ã¯2-3æéçµéå¾ã«é½æ§ã®ç·ãç¾ããã±ã¼ã¹ãç¶åºãã¦ããã¾ããæåæ¤æ»ããããå©ç¨ããéã¯2-3æéã¯å¿ ãæ¾ç½®ãã¦æ°é·ã«å¾ ã¡ã¾ãããï¼ . [æåæ¤æ»ãããæ§è½ï¼ç²¾åº¦ã»æåº¦ï¼æ¯è¼] . 2022å¹´2æç¾å¨ãã¹ãã«ã¹ãªãã¯ãã³æ ªããªãã¯ãã³äºç¨®ã¨ãã£ãæ°ããæ ªãä¸éã§ã¯é¨ããã¦ãã¾
åæçé·æ¥å¸ã§å ¨ä½æ°ã対象ã«PCRæ¤æ»ã宿½ï¼2022å¹´3æ16æ¥æä¾ï¼ã(c)CGTN Japanese ã3æ16æ¥ CGTN Japaneseãä¸å½å½å®¶è¡çå¥åº·å§å¡ä¼å»æ¿å»ç®¡å±ã®ç¦é è¼ï¼Jiao Yahuiï¼å±é·ã15æ¥ãå½å颿æçå ±åäºé²ã»æå¶ã¡ã«ããºã çºè¡¨ä¼ã§æããã«ããã¨ããã«ããã¾ãã¨ã2022å¹´3æ13æ¥ç¾å¨ãå ¨å½ã§åããã¦1ä¸2400ã®æ©é¢ãæ°åã³ããã¦ã¤ã«ã¹ã®PCRæ¤æ»ãµã¼ãã¹ãæä¾ãã¦ããããã¡å»çæ©é¢ã8864æ½è¨ãç¾ç ç®¡çæ©é¢ã2733æ½è¨ã第ä¸è æ¤æ»å®é¨å®¤ã803æ½è¨ã ã¨ãããã¨ã§ãã ç¾å¨ãä¸å½å ¨ä½ã®PCRæ¤æ»è½åã¯1æ¥å½ãã4609ä¸ä»¶ã«éãã¦ãã¾ãã ä¸å½ã¯2020å¹´ãäºã¤ã®æ¤ä½ãä¸ã¤ã®ãã¥ã¼ãã«å ¥ãã¦ä¸åº¦ã«èª¿ã¹ãæè¡ã2021å¹´ã«ã¯10人åã®æ¤ä½ãä¸åº¦ã«æ¤æ»ããæ¤ä½ãã¼ã«æ¤æ»æ³ãéçºãã¾ããã2022å¹´åãã«ãããã«ãã®ãã¼ã«æ¹å¼ã®æ¤æ»è½åãé«ãã20
ã«ãã«ã¯27æ¥ãæ°åã³ããã¦ã¤ã«ã¹ã®å¤ç°åããªãã¯ãã³åããæ¤åºããPCRæ¤æ»è©¦è¬ã2022å¹´1æã«çºå£²ããã¨çºè¡¨ããã1æéç¨åº¦ã§ãªãã¯ãã³åã¨ãã«ã¿åã®ã¦ã¤ã«ã¹ãç¹å®ã§ãããå½å ã§ã¯ã¿ã«ã©ãã¤ãªãå³¶æ´¥è£½ä½æããªãã¯ãã³åãæ¤åºã§ãã試è¬ãåææã«çºå£²ãããã«ãã«ã®æ¤æ»è©¦è¬ã¯ãæ°åã³ããã®é½æ§åå¿ãåºãæ£è ã®å¾æ¶²ãªã©ã«å«ã¾ããã¦ã¤ã«ã¹ã®è¡¨é¢æ§é ã®éã
Innovative Techï¼ ãã®ã³ã¼ãã¼ã§ã¯ããã¯ããã¸ã¼ã®ææ°ç ç©¶ãç´¹ä»ããWebã¡ãã£ã¢ãSeamlessãã主宰ããå±±ä¸è£æ¯ æ°ãå·çãæ°è¦æ§ã®é«ãç§å¦è«æã山䏿°ãããã¯ã¢ãããã解説ããã ç±³ã«ãªãã©ã«ãã¢å¤§å¦ãµã³ãã£ã¨ã´æ ¡ï¼UCSDï¼ã®ç ç©¶ãã¼ã ã¯ãå¸è²©ã®ãã¹ã¯ã«è²¼ãä»ããããã·ã¼ã«ã¿ã¤ãã®ä½¿ãæ¨ã¦ãã¹ãã¹ããªããï¼ç°¡æè©¦é¨ç´ï¼ãéçºããããã®ãã¹ãã¹ããªããã¯ãäººã®æ¯ã徿¶²ã«å«ã¾ããæ½å¨çãªæ°åã³ããã¦ã¤ã«ã¹ï¼SARS-CoV-2ï¼ãæ¤åºããã¨ããã
ãã®è¨äºã¯ C# Advent Calendar 2020 ã® 8 æ¥ç®ã®è¨äºã§ãã Microsoft å ¬å¼ããã¥ã¡ã³ã .NET ã§ã®ãã¹ã - .NET Core | Microsoft Docs ã«è¨è¼ããã¦ãã主è¦ãªä¸ã¤ã® xUnit, NUnit, MSTest ãã¬ã¼ã ã¯ã¼ã¯ãæ¯è¼ãã¦ã¿ã¾ãã çµè«ãã©ãã使ãã¹ãã æ°ããããã¸ã§ã¯ããªã xUnit ã NUnit ã使ãã¨ããã¨æãã¾ããéå»ã®ããã¸ã§ã¯ãã®ãã¤ã°ã¬ã¼ã·ã§ã³ãªããã®ããã¸ã§ã¯ãã§ä½¿ã£ã¦ãããã¬ã¼ã ã¯ã¼ã¯ã§ããã¨æãã¾ãã Visual Studio ããã®å®è¡ã CLI (dotnet test) ã®å®è¡ãä¾å¤ãã¹ãããã¼ã¿ããªãã³ãã¹ã (Theory, DataSource) ã¨ãã£ã主è¦ãªæ©è½ã¯ã©ã®ãã¬ã¼ã ã¯ã¼ã¯ã§ã対å¿ãã¦ãã¾ãã å人çã«ã¯ xUnit ã®æ¸ãæ¹ã好ããªã®ã§ xUnit ã使ãã
ãªãªã¼ã¹ãé害æ å ±ãªã©ã®ãµã¼ãã¹ã®ãç¥ãã
ææ°ã®äººæ°ã¨ã³ããªã¼ã®é ä¿¡
å¦çãå®è¡ä¸ã§ã
j次ã®ããã¯ãã¼ã¯
kåã®ããã¯ãã¼ã¯
lãã¨ã§èªã
eã³ã¡ã³ãä¸è¦§ãéã
oãã¼ã¸ãéã
{{#tags}}- {{label}}
{{/tags}}